Oaktree Specialty Lending

Q2 Earnings Highs And Lows: Oaktree Specialty Lending (NASDAQ:OCSL) Vs The Rest Of The Specialty Finance Stocks

1 Unpopular Stock That Deserves Some Love and 2 We Turn Down

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Oaktree Specialty Lending Prices $300 Million Debt Offering

Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 7.000% Notes due 2031

LOS ANGELES, September 09, 2026--Oaktree Specialty Lending Corporation (NASDAQ: OCSL) ("OCSL" or the "Company"), a specialty finance company, today announced that it has priced an underwritten public offering of $300.0 million aggregate principal amount of 7.000% notes due 2031. The notes will mature on September 16, 2031 and may be redeemed in whole or in part at the Company’s option at any time at par plus a "make-whole" premium, if applicable.

Oaktree Specialty Lending: Deeply Discounted 10%-Yielder Is Still Missing One Big Catalyst

The Top 5 Analyst Questions From Oaktree Specialty Lending’s Q2 Earnings Call

Oaktree Specialty Lending’s second quarter results reflected ongoing efforts to reduce portfolio risk and maintain balance sheet flexibility, even as revenue declined compared to last year. Management emphasized that the main drivers were lower non-accruals and selective investment deployment, highlighting the successful exit of several challenged positions, notably Thrasio. President Mathew Pendo commented, "More than 85% of the decline in non-accrual dollars over the past year is due to procee